Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Response Biomedical’s RAMP® platform and associated rapid diagnostic tests are commercially available worldwide. Their products deliver lab-quality results in minutes for acute care settings across cardiovascular disease diagnosis/management (e.g., heart failure via NT-proBNP; AMI via Troponin I/Myoglobin/CK-MB; D-dimer for VTE); infectious diseases such as COVID‑19 antigen testing; respiratory viruses like RSV and influenza; sepsis markers like procalcitonin; women’s health with hCG testing; arboviruses such as WNV/dengue/Zika; and biodefense. The company has a proven track record of precision with their assays calibrated to central laboratory standards[7][8][9][10].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Response Biomedical.